Top Institutions in Antibody-Drug Conjugate (ADC) Analytical Characterization and Process Monitoring
Leading institutions utilize cutting-edge chromatography and mass spectrometry methods to enhance ADC process understanding, enabling real-time reaction monitoring and detailed characterization of drug-to-antibody ratios and drug load distributions. These methodologies often involve native separation techniques and innovative mobile phases to improve retention and compatibility with MS.
-
#1
Genentech
South San Francisco, CA
Genentech leads in ADC analytical characterization with pioneering work in coupling HIC and MS for real-time process monitoring, including innovative use of ammonium tartrate as a mobile phase to enhance retention and MS compatibility.
Key Differentiators
- Biopharmaceutical Development
- Analytical Chemistry
- Antibody-Drug Conjugates
-
#2
University of Wisconsin-Madison
Madison, WI
UW-Madison has contributed foundational research in coupling HIC with MS for native protein analysis, inspiring subsequent innovations in ADC characterization techniques.
Key Differentiators
- Mass Spectrometry
- Protein Chemistry
- Analytical Biochemistry
-
#3
AbbVie
North Chicago, IL
AbbVie has been instrumental in advancing multi-dimensional LC-MS setups and improving analytical workflows for ADC characterization, contributing to the development of native separation techniques compatible with mass spectrometry.
Key Differentiators
- Biopharmaceutical Research
- Analytical Method Development
- ADC Development
-
#4
PolyLC, Inc.
Columbia, MD
PolyLC has developed specialized chromatography media and contributed expertise in coupling HIC with MS, facilitating improved separation and analysis of complex biotherapeutics including ADCs.
Key Differentiators
- Chromatography Technologies
- Analytical Instrumentation
- Biopharmaceutical Analysis
-
#5
Fred Hutchinson Cancer Center
Seattle, WA
Fred Hutchinson has contributed to the understanding of ADC bioconjugation chemistry and analytical characterization, supporting translational applications of ADCs in oncology.
Key Differentiators
- Cancer Therapeutics
- Bioconjugation Chemistry
- Translational Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
About the Author(s)
James Strachan
Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at. From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.
